Precision neuromodulation has reached a new threshold of noninvasive efficacy. Researchers have successfully utilized focused ultrasound (fUS) to target the cholinergic anti-inflammatory pathway (CAP) at the sub-organ level.
This technique employs low-intensity pulsed ultrasound to stimulate neural projections from the vagus nerve directly into visceral organs, such as the spleen. In models of colitis, this stimulation resulted in a 60% reduction in tissue damage.
Pro-inflammatory cytokines, specifically TNF-α and IL-6, were suppressed by 50-70%. The mechanism involves the activation of splenic nerve terminals, triggering acetylcholine release onto α7 nicotinic receptors.
This biochemical cascade inhibits NF-κB signaling within immune cells. The result is a controlled dampening of the inflammatory response without surgical intervention or implanted hardware.
Guided by real-time imaging, the method demonstrates precision comparable to invasive vagus nerve stimulation. This represents a significant advancement in bioelectronic medicine, utilizing acoustic energy to modulate systemic immunity.